Clinical Trial Update: Safety Study of BMS-770767 in Subjects With Type 2 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 safety study of BMS-770767 in subjects with Type 2 diabetes mellitus has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• BMS-770767

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Diabetes Type 2 | Phase 2 | Status: COMPLETED